OpenAI updates GPT-Rosalind, integrating GPT-5.5's agentic tool use and coding for specialized drug discovery and molecular design

From: OpenAI updates GPT-Rosalind, integrating GPT-5.5's agentic tool use and coding for specialized drug discovery and molecular design

Greg Brockman@gdb·11hQuote tweet

Major upgrade to GPT-Rosalind, with much better intelligence for drug discovery, analysis, design, and experimental workflows:

OpenAI@OpenAI·12hView on

We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale. It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows. https://openai.com/index/introducing-new-capabilities-to-gpt-rosalind

View on